The healthcare app creator reportedly shelves a Hong Kong listing in favor of "China's Nasdaq" due to data privacy and transparency concerns.
There's a lot going on right now and the markets (and media) have difficulty latching on to more than three or four stories at a time.
A Hong Kong-listed mainland Chinese property developer has shelved the purchase of a billion-dollar land plot in the city, walking away from a hefty deposit. It blames political chaos.
Wetting my whistle with these 2 beer names, plus 2 stocks to avoid.
Chinese authorities are auditing the books of 77 drugmakers, including three multinationals, they say were selected at random. Were they motivated by embarrassment over a college-admissions payment made by a Chinese pharmaceuticals' tycoon?
Trade tariffs have a cost for everyone, despite what the administration might say.
It is tough to build a position in this murky market.
Dealing with fears around the trade war with China and antitrust investigations, investors should know not only if customers are doing well, but also who a company's customers really are.
Growth will keep falling off a cliff unless Fed Powell comes to the rescue. But it is unclear whether he can, or will.
Be careful backing Buffett right now, his biggest holdings show increasing profit pressure.